Forgent Reports Fiscal Q1 2027 Results Above Guidance, Raises Outlook
Forgent said fiscal first-quarter 2027 results exceeded the high end of guidance and raised its full-year outlook, citing strong commercial and operational execution.
Related stories
Aveanna Healthcare Raises 2026 Revenue Guidance as Q3 Earnings and Revenue Rise
M impact | EQUITY | Nov 12, 2026, 12:36 PM UTC
Serco to Acquire QinetiQ’s U.S. Business for $292 Million
Serco Group is buying QinetiQ’s U.S. business for $292 million to build its U.S. defense platform. BNP Paribas analyst Daniel Cowan calls the deal timely and attractive.
M impact | EQUITY | Nov 12, 2026, 12:34 PM UTC
Brookfield Q3 Distributable Earnings Per Share Rise 16% to USD 0.73
M impact | EQUITY | Nov 12, 2026, 12:33 PM UTC
Cellebrite Q3 Non-GAAP Earnings and Revenue Rise; 2026 Revenue Guidance Lowered
Cellebrite reported higher Q3 non-GAAP earnings and revenue and lowered its 2026 revenue guidance.
M impact | EQUITY | Nov 12, 2026, 12:33 PM UTC
Apotex Reports Second-Quarter Results, Raises Fiscal 2027 Guidance
Apotex reported second-quarter fiscal 2027 results and raised its full-year fiscal 2027 guidance.
M impact | EQUITY | Nov 12, 2026, 12:33 PM UTC
Meta Prepayment Supports HALEU Purchase for Oklo's Ohio Campus
Meta's prepayment supports an HALEU purchase for Oklo's 1.2 GW Ohio campus.
M impact | EQUITY | Nov 12, 2026, 12:33 PM UTC